- Pharmacology
- Allergy, Immunology, and ENT
- Cardiology
- Emergency Medicine
- Endocrinology
- Adolescent Medicine
- Gastroenterology
- Infectious Diseases
- Neurology
- OB/GYN
- Practice Improvement
- Gynecology
- Respiratory
- Dermatology
- Mental, Behavioral and Development Health
- Oncology
- Rheumatology
- Sexual Health
- Pain
Teens & the HPV vaccine
The CDC releases its numbers on how many adolescents receive the human papillomavirus vaccine.
According to the assistant surgeon general and director of CDC’s National Center for Immunization and Respiratory Diseases, Anne Schuchat, MD, uptake continues to be “unacceptably low” on the vaccine that can protect adolescents against human papillomavirus (HPV) infection today and cancer in later life. “Frustrating” was how she deemed having to report virtually the same coverage level for girls for yet another year.
Schuchat’s July 23rd briefing was an affidavit on chances lost. Pediatricians and PCPs, Schuchat contends, are uniquely situated to prevent missed opportunities by inoculating against HPV when Tdap and meningococcal vaccines are administered.
Hear the briefing http://1.usa.gov/1s6BTMF
Read the briefing transcript http://1.usa.gov/1ltDJmP
Read the CDC MMWR Report http://1.usa.gov/1rdFRT9
BNT162b2 COVID vaccine effective in children amid Delta, Omicron periods
January 17th 2024Investigators of a study published in Annals of Internal Medicine concluded that the BNT162b2 COVID-19 vaccine demonstrated efficacy against the Delta and Omicron variants of COVID-19 in children and adolescents, offering new, extended follow-up period data.
